Bob Lederer RFL Communications, Inc.

Social Media’s Many MR Contributions To Pharma / RBDR

Do you regularly watch RBDR, whether once or up to four times a week? Do you find it informative and entertaining? Help maintain and continue our video based on what you can afford (e.g., $5 or $10 for an individual, perhaps $25 to $50 from a business per month). Visit Patreon.com/RBDR.

Today on RBDR: The pharmaceutical and healthcare industries have traditionally been slow to adopt new research tools, technologies and techniques. The use of social media, however, is a notable exception and SM has elevated information collection, quality and comprehension.

No need to spend time searching for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the latest RBDR is uploaded. Click here: http://ow.ly/CfFWE

Bob Lederer PRVR

Google Genomics. Watson & genetics. Pharmacos: PROs, personalized med (PRVR 11.17.14)

To subscribe to PRVR and receive an email with multiple links to the latest video report, please click: http://ow.ly/Clawn

Pharma Research VIDEO Report, a co-partnered production with the Pharmaceutical Marketing Research Group, is sponsored this week by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find out about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview
On this PRVR:

1) Google Genomics plans to store individuals’ genomes in the cloud, where they can be analyzed en masse by healthcare researchers.
Link: http://bigthink.com/ideafeed/for-new-era-of-personalized-medicine-google-to-store-individual-genomes-in-the-cloud

2) The IBM Watson program has invested in Pathway Genomics, which will use Watson’s computing prowess to offer a consumer app that can provide answers to personal health questions.
Link: http://www.thestreet.com/story/12950769/1/how-ibm-and-watson-plan-to-use-your-genetic-code-to-help-you-live-longer.html

3) Except for Jannsen, Novartis and Roche, few of the top 12 pharmaceutical companies are commercially ready for a personalized medicine business model
Link: http://www.diaceutics.com/new-report-reveals-most-leading-pharma-companies-still-not-commercially-ready-personalized-medicine

4) Patient Reported Outcomes (PROs) are of interest to pharmaceutical companies in their marketing strategies, but they are not finding buy-in from regulatory agencies.
LInk: http://www.marketwired.com/press-release/drug-makers-report-average-22-patient-reported-outcomes-endpoints-appear-on-final-product-1966590.htm

5) Sentrian’s remote patient intelligence platform plans to spot individuals’ impending health problems before they require hospitalization.
Link: http://www.prnewswire.com/news-releases/sentrian-the-worlds-first-remote-patient-intelligence-company-launches-to-eliminate-preventable-hospitalization-282122331.html

Bob Lederer PRVR

Patients not fulfilling 1st Rxs. Google looking for cancer-detection pill. (PMVR 11.03.2014)

This edition of Pharma Research VIDEO Report, a production in partnership with the Pharmaceutical Marketing Research Group, is sponsored by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find out about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview

On this weeks’ PRVR:

1) Proteus Digital Healthcare is entering the consumer (non-medical) market with a biometric monitoring patch.
Link to story: http://mobihealthnews.com/37784/proteus-digital-health-quietly-launches-consumer-facing-wearable-for-athletes/

2) NEHI cautions that the U.S. healthcare system needs to do something about patients failing to order and fulfill new prescriptions.
Link to story: http://www.nacds.org/Home/TabId/107/PostId/5179/Prescriptions-Never-Picked-Up-At-Pharmacy-A-Cause-For-Concern.aspx

3) Salesforce.com, which has been seriously interested in entering the healthcare market, is reportedly ready to make it a go, according to Orthospine News.
Link to story: http://www.allsalesforce.com/articles/share/682492/

4) Google announced it is developing a cancer-detection pill.
Link to story: http://www.huffingtonpost.ca/2014/10/29/google-nanotechnology-cancer-detecting-pill_n_6064266.html

5) dunnhumby’s “Healthy Wealthy & Wise” study shows brands why consumers who are health-committed are so attractive. (They tend to be more affluent than the average consumer.)
Link to story: http://www.cnbc.com/id/102131839

Bob Lederer PRVR

(PMVR 10.20.2014) Matt Campion reveals meanings of KOL has been evolving.

To subscribe to PRVR and receive an email with multiple links to the latest video report, please click: http://ow.ly/Clawn

Pharma Research VIDEO Report, a co-partnered production with the Pharmaceutical Marketing Research Group, is sponsored this week by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find everything you could want to know about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com

1) CVS Health has 41 partnerships in place with health system partners to try to stem readmittance to hospitals by better understanding Rx complications.

(http://www.fool.com/investing/general/2014/10/13/cvs-health-corps-new-prescription-for-growth.aspx)

2) The Sunshine Act’s Open Payment website revises its 2013 reported payment by pharmaceutical companies to MDs, adding $1.1 billion to the $3.5 billion initially reported.

( http://medcitynews.com/2014/10/open-payments-didnt-include-1b-first-roll/)

3) Stanford University’s new Center for Medical Mobile Technology will capture measurable, meaningful wearable device data.

(http://www.mhealthnews.com/news/stanford-launches-research-center-wearables)

4) Schlesinger Associates’ Matt Campion speaks to PRVR about KOLs and their variable importance among pharmaceutical market research stakeholders.

Bob Lederer PRVR

FDA oversight of med devices questioned. What MDs want from Apple Watch (PMVR 10.13.2014)

To subscribe to PRVR and receive an email with multiple links to the latest video report, please click: http://ow.ly/Clawn

Pharma Research VIDEO Report, a co-partnered production with the Pharmaceutical Marketing Research Group, is sponsored this week by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find everything you could want to know about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview

On this PRVR: 1) Two separate studies call the FDA to task for its oversight of new medical devices. (http://articles.philly.com/2014-10-01/news/54479968_1_lower-risk-devices-regulating-medical-devices-the-fda)

2) An MD explains what physicians would like to see from new smart watches that the Apple Watch does not offer. (http://www.forbes.com/sites/robertpearl/2014/10/02/a-doctors-take-on-the-apple-watch/)

3) Psilos Group’s annual healthcare outlook recommends that healthcare insurers ditch their B2B model and focus on patients and providers. (http://www.mhealthnews.com/news/insurers-must-change-and-embrace-mhealth-survive)

4) The pharma profession is noticeably slow in adopting mobile technologies despite the industry’s rabid interest and desire for them. (http://www.mhealthnews.com/news/pharmas-tough-road-mobility)

5) Facebook is rumored to be developing two entries for the pharmaceutical and healthcare markets. (http://www.healthtechzone.com/topics/healthcare/articles/2014/10/06/390696-facebook-eying-healthcare.htm)